- July 22, 2011 - UTRECHT, Netherlands --
ALH Nutritional Research, the semi-independent research and development (R&D) department of EBPC Pharmaceuticals, intends with this press release to elucidate its primary focus in current research.
To further strengthen the scientific basis of ALH Nutrition's Phenivir™ (phenibetan)
product series, ALH Nutritional Research will devout a significant part of its resources on research concerning these products. Phenivir™ will be the primary focus of research at ALH Nutritional Research until at least 2012.
All (current) research project on other subjects will received less attention.
UPDATE 23-07: ALH Nutritional Research reports planning 2PS (Phenibetan Pilot Study): To study the effects of short-term phenibetan treatment on several immune parameters.